5.22
price down icon1.51%   -0.08
after-market Handel nachbörslich: 5.18 -0.04 -0.77%
loading

Fibrogen Inc Aktie (FGEN) Neueste Nachrichten

pulisher
Jun 16, 2025

FibroGen (FGEN) Trading Halted Pending News Release | FGEN Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 13, 2025

FibroGen Enters New Agreement with HiFiBiO - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Fibrogen IncOn June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

FibroGen (FGEN) Announces 1-for-25 Reverse Stock Split | FGEN St - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

FibroGen to implement 1-for-25 reverse stock split; shares down 15% - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Jun 13, 2025
pulisher
Jun 12, 2025

Adobe, RH And 3 Stocks To Watch Heading Into FridayAdobe (NASDAQ:ADBE), FibroGen (NASDAQ:FGEN) - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen Announces 1-for-25 Reverse Stock Split | FGEN Stock New - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen Announces Reverse Stock Split Effective June 16 - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen to Implement 1-for-25 Reverse Stock Split - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen To Implement 1-for-25 Reverse Stock Split - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen, Inc. Announces 1-for-25 Reverse Stock Split Effective June 16, 2025 - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Fibrogen Announces 1-For-25 Reverse Stock Split - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen Announces 1-for-25 Reverse Stock Split - GlobeNewswire

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen's Massive 1-for-25 Reverse Split Cuts 101M Shares to 4MWhat Investors Must Know - Stock Titan

Jun 12, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Lowers Stock Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

FibroGen expands board with biotech veteran Kauffman By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen expands board with biotech veteran Kauffman - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Amends Financing Agreement for Flexibility - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors | FGEN Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Fibrogen Appoints Michael Kauffman To Its Board Of Directors - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Strengthens Board with Velcade Developer: Key Move for Pipeline Advancement - Stock Titan

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Takes Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Has $465,000 Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jun 05, 2025
pulisher
May 19, 2025

FibroGen, Inc. (NASDAQ:FGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 17, 2025

FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

FibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline - MSN

May 17, 2025
pulisher
May 16, 2025

FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

FibroGen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Has Negative Outlook for FibroGen Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

FibroGen’s Earnings Call: Strategic Gains Amid Revenue Woes - TipRanks

May 15, 2025
pulisher
May 15, 2025

FibroGen (NASDAQ:FGEN) Earns Buy Rating from HC Wainwright - Defense World

May 15, 2025
pulisher
May 14, 2025

FibroGen (FGEN) Boosts Sale Proceeds from Chinese Division - GuruFocus

May 14, 2025
pulisher
May 13, 2025

FibroGen (FGEN) Receives Reaffirmed Buy Rating from HC Wainwrigh - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen, Inc. (NASDAQ:FGEN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc earnings beat by $0.15, revenue fell short of estimates - Investing.com UK

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid Revenue Decline - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen Reports Q1 2025 Earnings and Strategic Updates - TipRanks

May 13, 2025
pulisher
May 12, 2025

Earnings call transcript: FibroGen Q1 2025 sees revenue drop, stock rises - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

FibroGen Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025
pulisher
May 12, 2025

FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimates at $2.7M, EPS Misses with $0.16 Loss - GuruFocus

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimat - GuruFocus

May 12, 2025
pulisher
May 12, 2025

FibroGen: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025
pulisher
May 12, 2025

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 12, 2025
pulisher
May 12, 2025

FIBROGEN INC SEC 10-Q Report - TradingView

May 12, 2025
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):